Atovaquone Suspension
Product Images NDC 72603-248

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 72603-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atovaquonestructure (Atovaquonestructure)

FDA Label Image

Atovaquoneoscarton (Atovaquoneoscarton)

FDA Label Image

Atovaquoneoscontainer (Atovaquoneoscontainer)

This text provides information about Atovaquone Oral Suspension, USP with a concentration of 750 mg/5 mL. It includes details on dosage, storage conditions, manufacturer, and regulatory license numbers. The product is intended for oral administration and should be dispensed in a tight container at temperatures between 15°C to 25°C. Users are advised not to freeze the product and to shake gently before use. The manufacturing details are listed for Northstar Rx LLC and Hetero Labs Limited in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.